Navigation Links
Snoasis Medical Initiates Distribution in Japan Through Hausten Healthcare
Date:7/27/2012

DENVER, July 27, 2012 /PRNewswire-iReach/ -- Snoasis Medical, Inc. formally announces the signing of a distribution agreement with Hausten Healthcare, LLC (Honolulu, HI), whereby Hausten Healthcare will distribute BioXclude™ in Japan.  While BioXclude is not approved for use by the Japanese Ministry of Health and Welfare, clinicians may legally import unapproved foreign medical products for treatment of patients in accordance with the Pharmaceutical Affairs Law. 

Hausten Healthcare is expected to begin distribution activities this coming fall.  Highly proficient in managing this unique regulatory landscape, Hausten Healthcare works in conjunction with Japanese clinicians to easily and efficiently navigate the importation process.  According to Robert Tofe, president and founder of Snoasis Medical, "we are currently seeking regulatory approval in Taiwan and South Korea, and are actively working to set up distribution in China.  Our relationship with Hausten allows access to Japan, one of the largest dental markets in the world, and punctuates our efforts to set up distribution throughout East Asia"

Amnion-chorion tissue is often referred to as the amniotic sac, the part of the placenta that encloses and protects the unborn baby through term.  This tissue is considered immunoprivileged, possesses anti-bacterial and anti-microbial properties, reduces inflammation at the wound site, and provides a protein-enriched matrix to naturally facilitate epithelialization and improve overall wound healing.  These attributes provide BioXclude with many benefits over traditional barrier membrane products used by dental professionals in guided bone and tissue regeneration procedures.

Founded in 2007, Snoasis Medical is focused on the development and commercialization of regenerative tissue and medical device products for use in dental surgery.  In 2008, Snoasis obtained the exclusive license and worldwide distribution rights to all current and future placental tissue products processed by Surgical Biologics, A MiMedx Group Company (Kennesaw, GA) for use in dentistry.  Snoasis Medical initiated commercial distribution of BioXclude in the United States in March 2010 and in Canada in September 2010.  For additional information, please visit www.SnoasisMedical.com.

Hausten Healthcare, LLC is a newly formed entity focused on providing Japanese dental clinicians, institutions and patients the best possible tissue regenerative options, some of which are not currently approved by the Japanese Ministry of Health and Welfare.  Created in June 2012, Hausten Healthcare was spun out of RHC Corporation, a company focused on providing Japanese physicians and medical institutions with a greater range of medical treatment options.  

Media Contact: Eric Frank Snoasis Medical, 303-242-8075, efrank@snoasismedical.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Snoasis Medical
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
2. DiaTech Life Sciences Announces Medical Advisory Board
3. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
4. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
5. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
6. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
7. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
8. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
9. Live Press Briefing on Findings of Biomedical Industry CEO Survey
10. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
11. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... Boston (PRWEB) , ... April 27, 2016 , ... ... driven by semantic web technology, today announced that it has been named to The ... life sciences, financial services and other markets, Cambridge Semantics serves the needs of end ...
(Date:4/27/2016)... and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) announced today that ... of United Therapeutics will provide an overview and update ... st Annual Health Care Conference. The ... at 10:00 a.m. Eastern Time, and can be accessed ...
(Date:4/27/2016)... ... April 27, 2016 , ... Global Stem Cells ... Advisory Board. Ross is the founder of GSCG affiliate Kimera Labs in Miami. , ... he studied hematopoietic stem cell transplantation for hematologic disorders and the suppression of graft ...
(Date:4/26/2016)... , ... April 26, 2016 , ... ... announced that Ardy Arianpour has joined the company as Chief Business Officer. Arianpour, ... bringing innovative genomic technologies to market, was most recently Chief Commercial Officer of ...
Breaking Biology Technology:
(Date:3/10/2016)... --  Unisys Corporation (NYSE: UIS ) today announced ... testing its biometric identity solution at the Otay Mesa border ... identify certain non-U.S. citizens leaving the country. ... determine the efficiency and accuracy of using biometric technologies in ... until May 2016. --> the United States ...
(Date:3/9/2016)... BEACH GARDENS, Fla. , March 9, 2016 ... identity management authentication and enrollment solutions, today announced ... DigitalPersona ® Altus multi-factor authentication ... IT and InfoSec managers to step-up security where ... Washington, DC . ...
(Date:3/3/2016)... March 3, 2016  2016FLEX, organized by FlexTech, ... highlighting advancements in flexible, hybrid and printed electronics. ... attendance - have gathered for short courses, technical ... of electronics. The Flex Conference celebrates its 15 ... companies, R&D organizations, and universities contributing to the ...
Breaking Biology News(10 mins):